Crinetics Pharmaceuticals, Inc. CRNX
$84.44
-0.02%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (7 Buy · 8 Hold · 0 Sell)
- Average Price Target
- $86.25
- Implied Upside
- +2.1%
- Price Target Range
- $52.00 – $143.00
- Analysts (12 mo)
- 15
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-28 | UBSAshwani Verma |
Downgrades | Buy → Neutral | $55 → $85 |
| 2026-07-08 | TD CowenTyler Van Buren |
Downgrades | Buy → Hold | — |
| 2026-07-08 | Evercore ISI GroupGavin Clark-Gartner |
Downgrades | Outperform → In-line | $88 → $85 |
| 2026-07-07 | Jones Trading |
Downgrades | Buy → Hold | $85 |
| 2026-07-07 | JefferiesDennis Ding |
Downgrades | Buy → Hold | $55 → $85 |
| 2026-07-07 | OppenheimerLeland Gershell |
Downgrades | Outperform → Perform | — |
| 2026-07-07 | Cantor FitzgeraldJosh Schimmer |
Downgrades | Overweight → Neutral | — |
| 2026-07-07 | HC Wainwright & Co.Douglas Tsao |
Downgrades | Buy → Neutral | $81 → $85 |
| 2026-07-07 | BairdBrian Skorney |
Maintains | Outperform | $62 → $85 |
| 2026-07-02 | UBSAshwani Verma |
Initiates coverage on | Buy | $55 |
| 2026-06-15 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $81 |
| 2026-06-11 | CitizensJonathan Wolleben |
Reiterates | Market outperform | $95 |
| 2026-05-15 | Evercore ISI GroupManeka Mirchandaney |
Maintains | Outperform | $89 → $88 |
| 2026-05-11 | OppenheimerLeland Gershell |
Maintains | Outperform | $87 → $84 |
| 2026-05-08 | CitizensJonathan Wolleben |
Maintains | Market outperform | $97 → $95 |
| 2026-04-28 | CitizensJonathan Wolleben |
Maintains | Market outperform | $96 → $97 |
| 2026-03-02 | CitizensJonathan Wolleben |
Maintains | Market outperform | $105 → $96 |
| 2026-01-12 | Goldman Sachs Richard Law |
Upgrades | Neutral → Buy | $67 |
| 2026-01-08 | CitizensJonathan Wolleben |
Maintains | Market outperform | $108 → $105 |
| 2026-01-06 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $77 → $80 |
| 2025-11-07 | CitizensJonathan Wolleben |
Maintains | Market outperform | $143 → $108 |
| 2025-09-30 | OppenheimerLeland Gershell |
Maintains | Outperform | $73 → $87 |
| 2025-09-29 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $65 → $77 |
| 2025-09-29 | Leerink PartnersJoseph Schwartz |
Maintains | Outperform | $80 → $88 |
| 2025-09-26 | Goldman Sachs Richard Law |
Maintains | Neutral | $35 → $40 |
| 2025-09-26 | JMP SecuritiesJonathan Wolleben |
Maintains | Market outperform | $86 → $143 |
| 2025-09-26 | BairdBrian Skorney |
Maintains | Outperform | $58 → $62 |
| 2025-09-24 | JP MorganJessica Fye |
Maintains | Overweight | $53 → $52 |
| 2025-08-11 | JMP SecuritiesJonathan Wolleben |
Maintains | Market outperform | $90 → $86 |
| 2025-06-27 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $81 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $84.44
- Market Cap
- $8.96 billion
- 52-Week Range
- $25.83 – $84.71
- Average Volume
- 6.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.